ILUVIEN patient case study library Phakic Eye Treatment Burden Managing IOP Vitrectomized Case 3 years of Iluvien Managing IOP Response “If the patient is not responding sufficiently to your current therapy, you owe it to them to treat the edema and trust either yourself or your colleagues to manage the rest, if needed.” — John W. Kitchens, MD Results presented below are from a single case; results may vary. John W. Kitchens, MD Dr. Kitchens is a partner and practicing retinal specialist at Retina Associates of Kentucky, the largest retina-only practice in the state. He has been voted one of the Best Doctors in America and one of America’s Top Ophthalmologists. Academic affiliations: Received his MD from the Indiana University School of Medicine Completed his ophthalmology residency at the University of Iowa Hospitals and Clinics Eye and Ear Infirmary followed by a vitreoretinal fellowship at the University of Chicago Department of Ophthalmology and Visual Sciences Was chief resident at Bascom Palmer Eye Institute in Miami, Florida, where he also completed his retinal fellowship Patient profile1 Sex: Male Age: 64 Diagnosis: DME Treated eye: OD Concomitant conditions: Poorly controlled type 2 diabetes mellitus Treatment history: • 1X Focal laser • 30X Anti-VEGF • 11X Corticosteroid Notes: Pseudophakic Reasons Dr. Kitchens chose ILUVIEN: Patient experienced a gradual waning of response to anti-VEGF therapy Patient concern with frequent injections Prior IOP elevation with corticosteroid therapy was managed effectively with topical drops and considered not clinically significant Desire to provide the patient with a long-lasting treatment Patient outcome Sustained visual acuity and reduction in retinal thickness for 14 months with just one additional anti-VEGF injection With ongoing topical therapy, no clinically significant rise in IOP has been observed Improvement was seen in both visual acuity and retinal edema “For this patient, I decided that ILUVIEN was the best course of therapy, despite his history of an IOP response. I pretreated him with drops and things seem to be going really well.” — John W. Kitchens, MD Retinal thickness (μm) Best corrected visual acuity (BCVA) Intraocular pressure (IOP) *Patient started IOP drops after first IV steroid treatment and remains on therapy Selected OCT Scans Baseline ILUVIEN injected Visual Acuity: 20/70 Letters: 55 OCT: 491 μm IOP: 14 mm Hg After treatment with ILUVIEN 1 month after Visual Acuity: 20/60 Letters: 60 OCT: 288 um IOP: 7 mm HG 1/4 5 months after Visual Acuity: 20/25 Letters: 80 OCT: 256 um IOP: 9 mm HG 2/4 12 months after Anti-VEGF injected Visual Acuity: 20/25 Letters: 80 OCT: 271 um IOP: 13 mm HG 3/4 14 months after Visual Acuity: 20/25 Letters: 80 OCT: 250 um IOP: 18 mm HG 4/4 MANAGING IOP CASEDownload a printable, pdf version of this case. DOWNLOAD CASEReal-world IOP DATAReview real-world IOP data from the USER Study. LEARN MORE